Thank you for your donation! Your payment is being processed. Please do not refresh or navigate away from this page.



Kelly L. Close is the founder and Chair of the Board of The diaTribe Foundation. Since 2006, she has been the Editor-in-Chief of diaTribe, our free website focused on making people with diabetes healthier and happier and advocating for action. Since 2002, she has also run Close Concerns, a healthcare information firm exclusively focused on diabetes and obesity. Each year Kelly and her colleagues attend over 50 scientific, regulatory, and economic conferences around the world, focused on diabetes and obesity. Kelly's passion for diabetes comes from her extensive professional work as well as her personal experience as a type 1 patient for nearly 30 years.


May 28, 2019

In May, the FDA announced an opportunity to submit feedback on what patients prefer in their medical devices to guide the agency’s regulatory decisions.

The agency has posted a ...

May 08, 2019

Early this year, Illinois Representative Bobby Rush introduced a bill to eliminate cost-sharing for insulin covered under Medicare Part D or Medicaid. The legislation, H.R. 366 – Insulin Access for All Act of 2019, proposes to get rid of deductibles, copayments, and coinsurance for insulin and any...

March 12, 2019

diaTribe Founder Kelly Close was recently part of an American Diabetes Association (ADA) panel on therapeutic inertia. According to the ADA, therapeutic inertia is “the failure to establish appropriate targets and escalate treatment to achieve treatment goals.” Said differently, therapeutic inertia is part of the reason why advances diabetes medicines, devices, and treatment strategies don’t...

March 01, 2019

A group of obesity experts was recently tasked with writing a report to address the obesity epidemic. Instead, the authors produced a 56-page document emphasizing the interconnectedness of obesity with undernutrition and global climate change. The commission argues that these three...

February 21, 2019

Certain older adults with type 2 diabetes can safely switch from analogue to human insulin, a new study suggests. After implementing a new formulary to encourage use of lower-cost human insulin, the average A1C among Medicare Advantage enrollees increased by 0.14%. For reference, a “clinically meaningful”...

How You Can Join Us

Sign Up For diaTribe Updates!

We will never sell your data and we promise to keep your details safe and secure. For more information see our privacy policy.